Why the study?
PPG-based devices can detect AF, but they are rarely integrated into hospital infrastructure to screen high-risk hospitalized patients in real time.
Does a fully automated PPG-based wearable system effectively screen for atrial fibrillation in hospitalized high-risk patients?
Observational (n=346)
No
Does a fully automated PPG-based wearable system effectively screen for atrial fibrillation in hospitalized high-risk patients?
A fully automated PPG-based wearable system for AF screening in hospitalized patients demonstrated high compliance and early arrhythmia detection, though no AF was confirmed by Holter ECG.
PPG wearables may flag arrhythmias in hospitalized patients but require validation; leaves open their utility for AF screening.
Background/Objectives: Atrial fibrillation (AF) remains a major risk factor for stroke. It is often asymptomatic and paroxysmal, making it difficult to detect with conventional electrocardiography (ECG). While photoplethysmography (PPG)-based devices like smartwatches have demonstrated efficacy in detecting AF, they are rarely integrated into hospital infrastructure. The study aimed to establish a seamless system for real-time AF screening in hospitalized high-risk patients using a wrist-worn PPG device integrated into a hospital’s data infrastructure. Methods: In this investigator-initiated prospective clinical trial conducted at the University Hospital Basel, patients with a CHA2DS2-VASc score ≥ 2 and no history of AF received a wristband equipped with a PPG sensor for continuous monitoring during their hospital stay. The PPG data were automatically transmitted, analyzed, stored, and visualized. Upon detection of an absolute arrhythmia (AA) in the PPG signal, a Holter ECG was administered. Results: The analysis encompassed 346 patients (mean age 72 ± 10 years, 175 females (50.6%), mean CHA2DS2-VASc score 3.5 ± 1.3)). The mean monitoring duration was 4.3 ± 4.4 days. AA in the PPG signal was detected in twelve patients (3.5%, CI: 1.5–5.4%), with most cases identified within 24 h (p = 0.004). There was a 1.3 times higher AA burden during the nighttime compared to daytime (p = 0.03). Compliance was high (304/346, 87.9%). No instances of AF were confirmed in the nine patients undergoing Holter ECG. Conclusions: This study successfully pioneered an automated infrastructure for AF screening in hospitalized patients through the use of wrist-worn PPG devices. This implementation allowed for real-time data visualization and intervention in the form of a Holter ECG. The high compliance and early AA detection achieved in this study underscore the potential and relevance of this novel infrastructure in clinical practice.
No takes yet. Share an insight, caveat, or question.
Abdelhamid et al. (2025) conducted an observational in Atrial fibrillation (n=346). Wrist-worn photoplethysmography (PPG) device was evaluated on Detection of an absolute arrhythmia (AA) in the PPG signal (95% CI 1.5-5.4).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: